
Chimerix Investor Relations Material
Latest events

FDA Announcement
Chimerix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Chimerix Inc
Access all reports
Chimerix Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases, including viral infections and cancer. The company's portfolio includes antiviral treatments and oncology therapies aimed at addressing unmet medical needs. Chimerix works on developing novel drug candidates to improve outcomes for patients with limited treatment options, particularly in areas such as immunotherapy and targeted therapies. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Key slides for Chimerix Inc


FDA Announcement
Chimerix Inc


FDA Announcement
Chimerix Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
CMRX
Country
🇺🇸 United States